Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Shree Sharma

Concepts (117)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Renal Cell
2
2010
101
0.650
Why?
Kidney Neoplasms
2
2010
174
0.620
Why?
Glomerulonephritis, Membranous
3
2020
27
0.520
Why?
Diabetic Nephropathies
1
2013
63
0.410
Why?
Kidney
2
2013
696
0.370
Why?
Angiogenesis Inducing Agents
1
2010
8
0.360
Why?
Glomerulonephritis, IGA
1
2010
5
0.360
Why?
PAX2 Transcription Factor
1
2010
22
0.360
Why?
Podocytes
1
2010
19
0.360
Why?
Carcinoma, Papillary
1
2010
47
0.350
Why?
Neovascularization, Physiologic
1
2010
68
0.340
Why?
Proto-Oncogene Proteins B-raf
1
2010
80
0.340
Why?
Diabetes Mellitus
1
2013
279
0.330
Why?
Vascular Endothelial Growth Factor A
1
2010
182
0.320
Why?
Neovascularization, Pathologic
1
2010
155
0.310
Why?
Angiogenesis Inhibitors
1
2010
183
0.300
Why?
Heart Diseases
1
2010
214
0.300
Why?
Immunohistochemistry
1
2010
957
0.290
Why?
Colorectal Neoplasms
1
2010
260
0.280
Why?
Adenocarcinoma
1
2010
397
0.260
Why?
Kidney Diseases
2
2019
213
0.230
Why?
Lupus Nephritis
1
2020
17
0.180
Why?
Lupus Erythematosus, Systemic
1
2020
69
0.170
Why?
Biopsy
2
2013
588
0.170
Why?
Glomerulonephritis
1
2019
14
0.170
Why?
Humans
13
2020
50503
0.130
Why?
Proflavine
1
2015
1
0.120
Why?
Endothelin-1
1
2015
31
0.120
Why?
Fluorescent Dyes
1
2015
103
0.120
Why?
Point-of-Care Systems
1
2015
57
0.120
Why?
Phenazopyridine
1
2014
3
0.110
Why?
Nephritis, Interstitial
1
2014
9
0.110
Why?
Contrast Media
1
2015
192
0.110
Why?
Glomerular Filtration Rate
1
2013
119
0.110
Why?
Myocardium
1
2015
445
0.100
Why?
Vascular Endothelial Growth Factors
1
2010
13
0.090
Why?
Microscopy, Electron, Transmission
1
2010
75
0.090
Why?
Colonic Neoplasms
1
2012
158
0.090
Why?
Proteinuria
1
2010
37
0.090
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2010
11
0.090
Why?
Hematuria
1
2010
26
0.090
Why?
Fluorescent Antibody Technique
1
2010
104
0.090
Why?
Fibroblast Growth Factors
1
2010
45
0.090
Why?
Neoplasms
1
2020
1251
0.090
Why?
Gene Expression Regulation
1
2015
955
0.090
Why?
Von Hippel-Lindau Tumor Suppressor Protein
1
2010
8
0.090
Why?
Patents as Topic
1
2010
9
0.090
Why?
DNA Mutational Analysis
1
2010
175
0.080
Why?
Integrins
1
2010
30
0.080
Why?
Female
5
2019
27081
0.080
Why?
Cell Nucleus
1
2010
182
0.080
Why?
Neoplasm Metastasis
1
2010
232
0.080
Why?
DNA, Neoplasm
1
2010
143
0.080
Why?
Matrix Metalloproteinases
1
2010
46
0.080
Why?
Amlodipine
1
2009
13
0.080
Why?
Genetic Therapy
1
2010
120
0.080
Why?
Aging
1
2015
693
0.080
Why?
Renal Insufficiency
1
2010
110
0.080
Why?
Fluorobenzenes
1
2009
22
0.080
Why?
Cardiomegaly
1
2009
39
0.080
Why?
TOR Serine-Threonine Kinases
1
2010
78
0.080
Why?
Stem Cell Transplantation
1
2010
179
0.080
Why?
Hypercholesterolemia
1
2009
38
0.080
Why?
Immunoglobulin G
2
2020
190
0.080
Why?
Calcium Channel Blockers
1
2009
62
0.080
Why?
Intracellular Signaling Peptides and Proteins
1
2010
135
0.080
Why?
Male
6
2020
25907
0.080
Why?
Sulfonamides
1
2009
126
0.080
Why?
Sensitivity and Specificity
1
2010
859
0.080
Why?
Pyrimidines
1
2009
191
0.070
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2009
138
0.070
Why?
Nanoparticles
1
2010
152
0.070
Why?
Drug Delivery Systems
1
2010
143
0.070
Why?
Predictive Value of Tests
1
2010
930
0.070
Why?
Diagnosis, Differential
1
2010
1033
0.070
Why?
Aged
3
2020
9741
0.070
Why?
Models, Biological
1
2010
716
0.070
Why?
Antibodies, Monoclonal
1
2010
462
0.060
Why?
Retrospective Studies
1
2013
6263
0.050
Why?
Middle Aged
2
2013
12611
0.050
Why?
Neural Cell Adhesion Molecules
1
2020
9
0.050
Why?
Thrombospondins
1
2020
8
0.040
Why?
Receptors, Phospholipase A2
1
2020
14
0.040
Why?
Calcium-Binding Proteins
1
2020
55
0.040
Why?
Autoantigens
1
2020
48
0.040
Why?
Autoantibodies
1
2020
117
0.040
Why?
Kidney Glomerulus
1
2019
37
0.040
Why?
Multiple Myeloma
1
2012
2998
0.040
Why?
Aspartic Acid Endopeptidases
1
2015
16
0.030
Why?
beta-Galactosidase
1
2015
32
0.030
Why?
Gene Knockdown Techniques
1
2015
105
0.030
Why?
Metalloendopeptidases
1
2015
69
0.030
Why?
Microscopy, Fluorescence
1
2015
158
0.030
Why?
Estrogen Receptor alpha
1
2015
88
0.030
Why?
Enzyme Activation
1
2015
268
0.030
Why?
RNA Interference
1
2015
178
0.030
Why?
Fibrosis
1
2015
181
0.030
Why?
Up-Regulation
1
2015
446
0.030
Why?
Fibroblasts
1
2015
336
0.030
Why?
Mice
2
2015
5687
0.020
Why?
Fatal Outcome
1
2012
197
0.020
Why?
Cell Line, Tumor
1
2015
1398
0.020
Why?
Cholesterol, Dietary
1
2009
19
0.020
Why?
Receptors, LDL
1
2009
67
0.020
Why?
Lipids
1
2009
152
0.020
Why?
Drug Therapy, Combination
1
2009
384
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
572
0.020
Why?
Signal Transduction
1
2015
1624
0.020
Why?
Body Weight
1
2009
517
0.020
Why?
Animals
2
2015
13124
0.020
Why?
Hematopoietic Stem Cell Transplantation
1
2012
578
0.020
Why?
Gene Expression
1
2009
610
0.020
Why?
Blood Pressure
1
2009
531
0.020
Why?
Mice, Knockout
1
2009
844
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2012
1000
0.020
Why?
Disease Models, Animal
1
2009
1436
0.010
Why?
Treatment Outcome
1
2009
5283
0.010
Why?
Sharma's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description